Navigation Links
Experimental Drug Seems to Aid Memory in Mice With Alzheimer's
Date:5/14/2013

TUESDAY, May 14 (HealthDay News) -- An experimental drug improved the memory and brain function in older mice with advanced symptoms of Alzheimer's disease, according to a new study.

Researchers from the Salk Institute in San Diego found that the drug, known as J147, increased levels of proteins that form the connections responsible for learning and memory, and reduced levels of a protein linked to cell death in the mice.

This explains how treating the mice with J147 led to an increase in factors that are necessary for correct memory function, according to the authors of the study, which was published online May 13 in the journal Alzheimer's Research & Therapy.

The effectiveness of J147 is the result of a new drug-discovery approach developed at the Salk Institute, said David Schubert, who heads the Cellular Neurobiology Laboratory.

"Our approach to screening drugs is very different from that currently used by pharmaceutical companies," Schubert said in a journal news release. "Alzheimer's disease is a complex disease associated with old age, and our goal is to make drugs like J147 that reduce the multiple toxicities associated with the disease, not just one.

"We believe that J147 is the best Alzheimer's disease drug candidate in the pipeline and will be effective if we can get it into the clinic," he added.

The researchers noted that separate studies found that J147 and another drug called donepezil (brand name Aricept) improved short-term memory and another form of memory commonly lost in Alzheimer's patients. They said that only J147 improved spatial memory, which relates to remembering information about places, such as knowing your way around your neighborhood.

Success in animal research is no guarantee of similar results in human research.

More information

The U.S. National Institute on Aging has more about Alzheimer's disease.

-- Mary Elizabeth Dallas

SOURCE: BioMed Central, news release, May 13, 2013


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Mayo Clinic finds experimental drug inhibits growth in all stages of common kidney cancer
2. Experimental Drug for Hepatitis C Promising, Studies Show
3. Experimental Vaccine Shows Promise for Ovarian Cancer
4. Cisplatin-resistant cancer cells sensitive to experimental anticancer drugs, PARP inhibitors
5. Experimental Staph Vaccine Fails to Work, Study Finds
6. Experimental Drug May Work Against Hepatitis C
7. Experimental Alzheimers Drug Shows Promise, Study Finds
8. Experimental Vitiligo Treatment Shows Promise in Mice
9. Harmful effects of bisphenol A proved experimentally
10. Experimental agent briefly eases depression rapidly in test
11. NIH-funded trial launched to assess experimental TB drug
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Experimental Drug Seems to Aid Memory in Mice With Alzheimer's
(Date:10/13/2017)... ... 2017 , ... As health professionals work to improve their approach to healthcare, ... doing more than filling out a survey; in many cases health professionals and patients ... health care and research on the importance of active engagement with patients and members ...
(Date:10/13/2017)... ... October 13, 2017 , ... The ... to promote standards of excellence for the field of eating disorders, announces the ... – 25, 2018 in Orlando, Florida at the Omni Resort at ChampionsGate. ...
(Date:10/13/2017)... ... ... Lori R. Somekh, founder of the Law Office of Somekh & Associates ... special needs planning attorneys. “Membership in ElderCounsel helps our office remain up to date ... elder law attorneys nationwide,” said Somekh. , ElderCounsel was founded by ...
(Date:10/13/2017)... ... October 13, 2017 , ... The Visiting Nurse Association (VNA) of Somerset Hills ... specialty vendors and unique items from across the nation, this holiday-themed event will raise ... offered by the VNA. The boutique will be open Saturday, November 4 (10:00 ...
(Date:10/13/2017)... ... October 13, 2017 , ... Yisrayl Hawkins, Pastor and Overseer ... one of the most popular and least understood books in the Holy Scriptures, Revelation. ... descriptions that have baffled scholars for centuries. Many have tossed it off as mere ...
Breaking Medicine News(10 mins):
(Date:9/25/2017)... 25, 2017   Montrium , an industry ... today—from the IQPC Trial Master Files & Inspection ... that EastHORN Clinical Services has selected eTMF ... TMF management. EastHORN, a leading European contract research ... increase transparency to enable greater collaboration with sponsors, ...
(Date:9/19/2017)... , Sept. 19, 2017 HistoSonics, Inc., a venture-backed medical device company developing ... of targeted tissues, announced three leadership team developments today:   ... ... ... Veteran medical device executive Josh Stopek ...
(Date:9/12/2017)... and NEW YORK , Sept. 12, 2017 ... performance ratings for global supply chains, has published the first annual edition ... CSR performance of more than 20,400 companies evaluated by EcoVadis, based on ... 2015 and 2016. ... EcoVadis Global CSR Risk & Performance Index ...
Breaking Medicine Technology: